response to placebo was considered a psychological trait related to neurosis and gullibility rather than a physiological phenomenon that could be scrutinized in the lab and manipulated for therapeutic benefit. But then Benedetti came across a study, done years earlier, that suggested the placebo effect had a neurological foundation. US scientists had found that a drug called naloxone blocks the pain-relieving power of placebo treatments. The brain produces its own analgesic compounds called opioids, released under conditions of stress, and naloxone blocks the action of these natural painkillers and their synthetic analogs.
1More
The view from over there: reframing the OSCE through the experience of standardised pat... - 1 views
1More
Student perspectives on assessment: Experience in a competency-based portfolio system, ... - 2 views
1More
Patient Blogging Could Offer Host of Benefits - Features - iHealthBeat - 2 views
20More
Placebos Are Getting More Effective. Drugmakers Are Desperate to Know Why. - 0 views
1More